Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
API
0
FDF
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
Molecular Weight | 5917 g/mol |
---|---|
Molecular Formula | C267H402N64O76S6 |
XLogP3 | -3.5 |
Hydrogen Bond Donor Count | 76 |
Hydrogen Bond Acceptor Count | 87 |
Rotatable Bond Count | 189 |
Exact Mass | 5914.7950469 g/mol |
Monoisotopic Mass | 5912.7883372 g/mol |
Topological Polar Surface Area | 2400 Ų |
Heavy Atom Count | 413 |
Formal Charge | 0 |
Complexity | 14700 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 50 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
1 of 4 | |
---|---|
Drug Name | Levemir |
PubMed Health | Insulin Detemir (Injection) |
Drug Label | LEVEMIR (insulin detemir [rDNA origin] injection) is a sterile solution of insulin detemir for use as an injection. Insulin detemir is a long-acting basal insulin analog, with up to 24 hours duration of action, produced by a proceb that includes e... |
Active Ingredient | Insulin detemir recombinant; Insulin detemir |
Dosage Form | Injectable |
Route | injection; Subcutaneous |
Strength | 100 units/ml; 1000 units/10ml (100 units/ml) |
Market Status | Prescription |
Company | Novo Nordisk |
2 of 4 | |
---|---|
Drug Name | Levemir flexpen |
Active Ingredient | Insulin detemir recombinant |
Dosage Form | Injectable |
Route | Subcutaneous |
Strength | 300 units/3ml (100 units/ml) |
Market Status | Prescription |
Company | Novo Nordisk |
3 of 4 | |
---|---|
Drug Name | Levemir |
PubMed Health | Insulin Detemir (Injection) |
Drug Label | LEVEMIR (insulin detemir [rDNA origin] injection) is a sterile solution of insulin detemir for use as an injection. Insulin detemir is a long-acting basal insulin analog, with up to 24 hours duration of action, produced by a proceb that includes e... |
Active Ingredient | Insulin detemir recombinant; Insulin detemir |
Dosage Form | Injectable |
Route | injection; Subcutaneous |
Strength | 100 units/ml; 1000 units/10ml (100 units/ml) |
Market Status | Prescription |
Company | Novo Nordisk |
4 of 4 | |
---|---|
Drug Name | Levemir flexpen |
Active Ingredient | Insulin detemir recombinant |
Dosage Form | Injectable |
Route | Subcutaneous |
Strength | 300 units/3ml (100 units/ml) |
Market Status | Prescription |
Company | Novo Nordisk |
Related Excipient Companies
Excipients by Applications
Global Sales Information
Patents & EXCLUSIVITIES
ABOUT THIS PAGE
A Levemir manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Levemir, including repackagers and relabelers. The FDA regulates Levemir manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Levemir API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Levemir manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Levemir supplier is an individual or a company that provides Levemir active pharmaceutical ingredient (API) or Levemir finished formulations upon request. The Levemir suppliers may include Levemir API manufacturers, exporters, distributors and traders.
click here to find a list of Levemir suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
Levemir Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Levemir GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Levemir GMP manufacturer or Levemir GMP API supplier for your needs.
A Levemir CoA (Certificate of Analysis) is a formal document that attests to Levemir's compliance with Levemir specifications and serves as a tool for batch-level quality control.
Levemir CoA mostly includes findings from lab analyses of a specific batch. For each Levemir CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Levemir may be tested according to a variety of international standards, such as European Pharmacopoeia (Levemir EP), Levemir JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Levemir USP).
LOOKING FOR A SUPPLIER?